
| Serial Number | 79314441 |
| Word Mark | AC AQUACELLE |
| Filing Date | Friday, April 23, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 15, 2022 |
| Registration Number | 6897520 |
| Registration Date | Tuesday, November 15, 2022 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, August 30, 2022 |
| Description of Mark | The mark consists of the stylized wording "AC AQUACELLE". |
| Goods and Services | Pharmaceutical products, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals all in the nature of pharmaceutical preparation for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; nutritional preparations for medical use, namely, medications used for the delivery and absorption of nutrients being pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; chemical products for use in medical or veterinary biotechnology, namely, chemical preparations for increasing bioavailability and absorption of active ingredients in foodstuffs and medicines, being pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; medicated food additives being pharmaceutical products that facilitate or increase the absorption of vitamins and minerals, namely, pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents |
| Pseudo Mark | AC AQUA CELLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 13, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Pharmako Biotechnologies Pty Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 82 - NOT AVAILABLE |
| Address | AU |
| Party Name | Pharmako Biotechnologies Pty Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 82 - NOT AVAILABLE |
| Address | AU |
| Party Name | Pharmako Biotechnologies Pty Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 82 - NOT AVAILABLE |
| Address | AU |
| Event Date | Event Description |
| Wednesday, March 29, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, March 8, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, March 8, 2023 | FINAL DISPOSITION PROCESSED |
| Wednesday, February 15, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 15, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 15, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, September 17, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Tuesday, August 30, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 30, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 10, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, July 28, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 14, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 13, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 13, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 8, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, July 8, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, July 8, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, July 8, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, July 8, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, July 8, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Sunday, January 30, 2022 | REFUSAL PROCESSED BY IB |
| Thursday, January 13, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, January 13, 2022 | REFUSAL PROCESSED BY MPU |
| Wednesday, December 22, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, December 21, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, December 17, 2021 | ASSIGNED TO EXAMINER |
| Saturday, July 17, 2021 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, July 13, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 8, 2021 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, July 1, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |